Vitonis Allison F, Vincent Katy, Rahmioglu Nilufer, Fassbender Amelie, Buck Louis Germaine M, Hummelshoj Lone, Giudice Linda C, Stratton Pamela, Adamson G David, Becker Christian M, Zondervan Krina T, Missmer Stacey A
Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Boston Center for Endometriosis, Boston Children's Hospital and Brigham and Women's Hospital, Boston, Massachusetts.
Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom.
Fertil Steril. 2014 Nov;102(5):1223-32. doi: 10.1016/j.fertnstert.2014.07.1244. Epub 2014 Sep 22.
To harmonize the collection of nonsurgical clinical and epidemiologic data relevant to endometriosis research, allowing large-scale collaboration.
An international collaboration involving 34 clinical/academic centers and three industry collaborators from 16 countries on five continents.
In 2013, two workshops followed by global consultation, bringing together 54 leaders in endometriosis research.
None.
INTERVENTION(S): Development of a self-administered endometriosis patient questionnaire (EPQ), based on [1] systematic comparison of questionnaires from eight centers that collect data from endometriosis cases (and controls/comparison women) on a medium to large scale (publication on >100 cases); [2] literature evidence; and [3] several global consultation rounds.
MAIN OUTCOME MEASURE(S): Standard recommended and minimum required questionnaires to capture detailed clinical and covariate data.
RESULT(S): The standard recommended (EPHect EPQ-S) and minimum required (EPHect EPQ-M) questionnaires contain questions on pelvic pain, subfertility and menstrual/reproductive history, hormone/medication use, medical history, and personal information.
CONCLUSION(S): The EPQ captures the basic set of patient characteristics and exposures considered by the WERF EPHect Working Group to be most critical for the advancement of endometriosis research, but is also relevant to other female conditions with similar risk factors and/or symptomatology. The instruments will be reviewed based on feedback from investigators, and-after a first review after 1 year-triannually through systematic follow-up surveys. Updated versions will be made available through http://endometriosisfoundation.org/ephect.
协调与子宫内膜异位症研究相关的非手术临床和流行病学数据的收集工作,以实现大规模合作。
一项国际合作项目,涉及来自五大洲16个国家的34个临床/学术中心以及三个行业合作伙伴。
2013年举办了两次研讨会,随后进行了全球咨询,汇聚了54位子宫内膜异位症研究领域的领军人物。
无。
基于以下几点开发了一份子宫内膜异位症患者自填问卷(EPQ):[1]对八个从中等规模到大规模收集子宫内膜异位症病例(以及对照/比较女性)数据的中心的问卷进行系统比较(发表病例数>100例);[2]文献证据;[3]多轮全球咨询。
用于获取详细临床和协变量数据的标准推荐问卷和最低要求问卷。
标准推荐问卷(EPHect EPQ-S)和最低要求问卷(EPHect EPQ-M)包含有关盆腔疼痛、生育力低下、月经/生殖史、激素/药物使用、病史和个人信息的问题。
EPQ涵盖了世界子宫内膜异位症研究基金会(WERF)EPHect工作组认为对推进子宫内膜异位症研究最为关键的患者特征和暴露情况的基本数据集,但也与具有相似风险因素和/或症状的其他女性疾病相关。这些问卷将根据研究者的反馈进行审查,并在1年后首次审查后,通过系统的随访调查每三年审查一次。更新版本将通过http://endometriosisfoundation.org/ephect提供。